Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › (Thieno[2,3-b][1,5]benzoxazepin-4-yl)piperazin-1-yl compounds as dual activity H1 inverse agonists/5-HT2A antagonists

(Thieno[2,3-b][1,5]benzoxazepin-4-yl)piperazin-1-yl compounds as dual activity H1 inverse agonists/5-HT2A antagonists

US Patent 9562057 · Granted Feb 7, 2017

Estimated economic value: $433,984,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted [(5H-pyrrolo[2,1-c][1,4]benzodiazepin-11-yl)piperazin-1-yl]-2,2-dime2012
2-[4-(pyrazol-4-ylalkyl)piperazin-1-yl]-3-phenyl pyrazines as 5-HT7 receptor ant2012
5-HT7 receptor antagonists2011
3-Aminopyrrolidines as inhibitors of monoamine uptake2009
Aminomethyl-azacycle derivatives as inhibitors of monoamine uptake2009
Morpholine derivatives as norepinephrine reuptake inhibitors2009
4-Amino-piperidine derivatives as monoamine uptake inhibitors2009
Pyridinylmorpholine derivatives2009
3-aminopiperidines and 3-aminoquinuclidines as inhibitors of monoamine uptake2008
3-aryloxy/thio-3-substituted propanamines and their use in inhibiting serotonin 2008
Propanamine derivatives as serotonin and norepinephrine reuptake inhibitors2008
3-aryloxy/thio-2,3-substituted propanamines and their use in inhibiting serotoni2008